Acarix AB: Acarix submits breakthrough designation request with FDA for heart failure diagnosis
Press release Malmö, Sweden, February 9, 2022 Acarix submits breakthrough designation request with FDA for heart failure diagnosis Acarix expands its portfolio and submits a breakthrough designation